Literature DB >> 24064289

Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan.

Wen-Wei Ku1, Che-Hsuang Kung1, Chi-Hung Lee1, Chih-Peng Tseng2, Ping-Feng Wu1, Shu-Chen Kuo3, Te-Li Chen4, Yi-Tzu Lee5, Fu-Der Wang6, Chang-Phone Fung6.   

Abstract

BACKGROUND: Carbapenem-resistant Acinetobacter baumannii has emerged as an important cause of nosocomial infections with high morbidity and mortality. The carbapenemases, especially class D carbapenem-hydrolyzing oxacillinases (CHDLs), play an important role, but the relationship between their prevalence trend and carbapenem resistance remains unclear.
MATERIALS AND METHODS: Between 1995 and 2012, we collected 667 isolates of A. baumannii from a single medical center in northern Taiwan. Pulsed-field gel electrophoresis (PFGE) was used to determine clonality. Antimicrobial susceptibility was determined. Carbapenemase genes and associated genetic structures were detected by polymerase chain reaction.
RESULTS: Isolates were heterogeneous on PFGE. Susceptibility to carbapenem decreased steadily over the study period from 88.1% (2001-2003) to <25% (2010-2012), whereas the isolates remained susceptible to colistin (nearly 100%) and partially susceptible to tigecycline (80%). Starting in 2001, isolates carrying the ISAba1-blaOXA-51-like allele were consistently identified. Isolates containing the transposons Tn2006 or Tn2008 first appeared in 2007 with increasing carriage rates from 17.5% (2007-2009) to 50.0% (2010-2012). The IS1008-ΔISAba3-blaOXA-58-like, blaOXA-72 and metallo-β-lactamase genes were detected only sporadically. Isolates carrying CHDL genes were resistant to multiple drugs, including carbapenem, but remained susceptible to colistin (100.0%).
CONCLUSION: Increased carbapenem resistance in A. baumannii may be caused by the increased prevalence of isolates containing the ISAba1-blaOXA-51-like allele and the transposons Tn2006 and Tn2008.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  ISAba1-bla(OXA-23-like); ISAba1-bla(OXA-51-like); Tn2006; Tn2008

Mesh:

Substances:

Year:  2013        PMID: 24064289     DOI: 10.1016/j.jmii.2013.07.005

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  4 in total

1.  Specific Amino Acid Substitutions in OXA-51-Type β-Lactamase Enhance Catalytic Activity to a Level Comparable to Carbapenemase OXA-23 and OXA-24/40.

Authors:  Kwan-Wai Chan; Chen-Yu Liu; Ho-Yin Wong; Wai-Chi Chan; Kwok-Yin Wong; Sheng Chen
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

2.  Multicenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy.

Authors:  Yi-Tzu Lee; Yung-Chih Wang; Shu-Chen Kuo; Chung-Ting Chen; Chang-Pan Liu; Yuag-Meng Liu; Te-Li Chen; Ya-Sung Yang
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

3.  Characterization of Carbapenemases in Extensively Drug Resistance Acinetobacter baumannii in a Burn Care Center in Iran.

Authors:  Leila Azimi; Malihe Talebi; Mohammad-Reza Pourshafie; Parviz Owlia; Abdolaziz Rastegar Lari
Journal:  Int J Mol Cell Med       Date:  2015

Review 4.  Multidrug Resistance (MDR) and Collateral Sensitivity in Bacteria, with Special Attention to Genetic and Evolutionary Aspects and to the Perspectives of Antimicrobial Peptides-A Review.

Authors:  András Fodor; Birhan Addisie Abate; Péter Deák; László Fodor; Ervin Gyenge; Michael G Klein; Zsuzsanna Koncz; Josephat Muvevi; László Ötvös; Gyöngyi Székely; Dávid Vozik; László Makrai
Journal:  Pathogens       Date:  2020-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.